US Patent 11124493 Nuclear transport modulators and uses thereof
Patent 11124493 was granted and assigned to Karyopharm Therapeutics Inc. on September, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11124493 Nuclear transport modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
